Cargando…
Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931971/ https://www.ncbi.nlm.nih.gov/pubmed/36598735 http://dx.doi.org/10.1007/s40744-022-00530-0 |
| _version_ | 1784889346724200448 |
|---|---|
| author | Combe, Bernard G. Tanaka, Yoshiya Buch, Maya H. Nash, Peter Burmester, Gerd R. Kivitz, Alan J. Bartok, Beatrix Pechonkina, Alena Xia, Katrina Emoto, Kahaku Kano, Shungo Hendrikx, Thijs K. Landewé, Robert B. M. Aletaha, Daniel |
| author_facet | Combe, Bernard G. Tanaka, Yoshiya Buch, Maya H. Nash, Peter Burmester, Gerd R. Kivitz, Alan J. Bartok, Beatrix Pechonkina, Alena Xia, Katrina Emoto, Kahaku Kano, Shungo Hendrikx, Thijs K. Landewé, Robert B. M. Aletaha, Daniel |
| author_sort | Combe, Bernard G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9931971 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99319712023-02-17 Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study Combe, Bernard G. Tanaka, Yoshiya Buch, Maya H. Nash, Peter Burmester, Gerd R. Kivitz, Alan J. Bartok, Beatrix Pechonkina, Alena Xia, Katrina Emoto, Kahaku Kano, Shungo Hendrikx, Thijs K. Landewé, Robert B. M. Aletaha, Daniel Rheumatol Ther Correction Springer Healthcare 2023-01-04 /pmc/articles/PMC9931971/ /pubmed/36598735 http://dx.doi.org/10.1007/s40744-022-00530-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Combe, Bernard G. Tanaka, Yoshiya Buch, Maya H. Nash, Peter Burmester, Gerd R. Kivitz, Alan J. Bartok, Beatrix Pechonkina, Alena Xia, Katrina Emoto, Kahaku Kano, Shungo Hendrikx, Thijs K. Landewé, Robert B. M. Aletaha, Daniel Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title_full | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title_fullStr | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title_full_unstemmed | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title_short | Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study |
| title_sort | correction: efficacy and safety of filgotinib in patients with high risk of poor prognosis who showed inadequate response to mtx: a post hoc analysis of the finch 1 study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931971/ https://www.ncbi.nlm.nih.gov/pubmed/36598735 http://dx.doi.org/10.1007/s40744-022-00530-0 |
| work_keys_str_mv | AT combebernardg correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT tanakayoshiya correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT buchmayah correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT nashpeter correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT burmestergerdr correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT kivitzalanj correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT bartokbeatrix correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT pechonkinaalena correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT xiakatrina correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT emotokahaku correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT kanoshungo correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT hendrikxthijsk correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT landewerobertbm correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study AT aletahadaniel correctionefficacyandsafetyoffilgotinibinpatientswithhighriskofpoorprognosiswhoshowedinadequateresponsetomtxaposthocanalysisofthefinch1study |